Antigen presentation by MHC class I and its regulation by interferon γ

Current Opinion in Immunology

Volumn 11, Issue 1, 1999, Pages 76-81

  Früh, Klaus ^a   Yang, Young ^a  

^a GENERAL ATOMICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSOL AMINOPEPTIDASE; EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN SUBUNIT;

ANTIGEN PRESENTATION; BIOCHEMISTRY; CRYSTALLOGRAPHY; GENE EXPRESSION REGULATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW;

EID: 0038899636     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80014-4     Document Type: Article

References (52)

1. Coux O, Tanaka K, Goldberg AL Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem. 65:1996;801-847.
2. Doherty PC The numbers game for virus-specific CD8+ T cells. Science. 280:1998;227.
3. Früh K, Karlsson L, Yang Y Gamma interferon in antigen processing and presentation. Karupiah G Gamma Interferon Antiviral Defense. 1997;39-59 Landes, Austin, Texas.
4. Niedermann G, Grimm R, Geier E, Maurer M, Realini C, Gartmann C, Soll J, Omura S, Rechsteiner MC, Baumeister W, Eichmann K Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system. J Exp Med. 186:1997;209-220. By comparing the peptide cleavage products of proteasomes purified from various organisms, the authors show that peptides corresponding to known epitopes can be produced by invertebrates. It is concluded that the ability to produce peptides has predated the evolution of the MHC system.
5. Akopian TN, Kisselev AF, Goldberg AL Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum. J Biol Chem. 272:1997;1791-1798.
6. Kisselev AF, Akopian TN, Goldberg AL Range of sizes of peptide products generated during degradation of different proteins by archaeal proteasomes. J Biol Chem. 273:1998;1982-1989. To determine the size of peptide products, the degradation of four unfolded proteins by archeabacterial proteasomes was determined using several experimental approaches. In contrast to [7], the peptide products displayed a wide range of lengths (from 3 to 30 residues) with no predominant length. If this result is confirmed for vertebrate proteasomes, the majority of degradation products would be outside the size range for peptides that bind MHC class I.
7. Wenzel T, Eckerskorn C, Lottspeich F, Baumeister W Existence of a molecular ruler in proteasomes suggested by the analysis of degradation products. FEBS Lett. 349:1994;205-209.
8. Benham AM, Neefjes JJ Proteasome activity limits the assembly of MHC class I molecules after IFN-γ stimulation. J Immunol. 159:1997;5896-5904.
9. Groll M, Ditzel L, Loewe J, Stock D, Bochtler M, Bartunik HD, Huber R Structure of 20S proteasome from yeast at 2.4 A resolution. Nature. 386:1997;463-471. Here, the crystal structure of the yeast proteasome revealed the assembly order for the seven different α- and β-type subunits. Overall the structure is remarkably similar to the thermoplasma proteasome [10] with the notable exceptions, firstly, that the entrance to the central cavity is obstructed by extensions from the α-type subunits and, secondly, that only three of the seven β-type subunits are catalytic. It might now be possible to design inhibitors that are specific for the individual catalytic sites.
10. Löwe J, Stock D, Jap B, Zwickl P, Baumeister W, Huber R Crystal structure of the 20 S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science. 268:1995;533-539.
11. Kasahara M New insights into the genomic organization and origin of the major histocompatibility complex: role of chromosomal (genome) duplication in the emergence of the adaptive immune system. Hereditas. 127:1997;59-65.
12. Ramos PC, Hockendorff J, Johnson ES, Varshavsky A, Dohmen RJ Ump1p is required for proper maturation of the 20S proteasome and becomes its substrate upon completion of the assembly. Cell. 92:1998;489-499. The authors show that the assembly of yeast proteasomes depends on a new type of chaperone which is degraded during proteasome maturation.
13. Nandi D, Woodward E, Ginsburg DB, Monaco JJ Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor β subunits. EMBO J. 16:1997;5363-5375.
14. Schmidt M, Kloetzel PM Biogenesis of eukaryotic 20S proteasomes: the complex maturation of a complex enzyme. FASEB J. 11:1997;1235-1243.
15. •].
16. •], MECL-1 was found to require LMP2 for incorporation. In addition, LMP7 is required for the maturation of the LMP2- and MECL-1-containing immunoproteasome. These data suggest that, upon IFN-γ induction, all three subunits are incorporated co-ordinately. Thus, only two populations of 20S proteasomes are mainly present in cells: the house-keeping proteasomes and the immunoproteasomes.
17. Heinemeyer W, Fischer M, Krimmer T, Stachon U, Wolf DH The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J Biol Chem. 272:1997;25200-25209.
18. Eleuteri AM, Kohanski RA, Cardozo C, Orlowski M Bovine spleen multicatalytic proteinase complex (proteasome). Replacement of X, Y, and Z subunits by LMP7, LMP2, and MECL1 and changes in properties and specificity. J Biol Chem. 272:1997;11824-11831.
19. Cardozo C, Kohanski RA Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the "immunoproteasome" J Biol Chem. 273:1998;16764-16770. This study compares the cleavage products obtained by using denatured lysozyme as a substrate for either 20S proteasomes isolated from bovine brain or immunoproteasomes from spleen. The immunoproteasome demonstrated an increased cleavage after branched chain residues, confirming results obtained with fluorogenic substrates [18]. In addition, a preference for small and hydrophobic residues at P2 and P3, respectively, was observed; this suggests a cleavage motif for immunoproteasomes.
20. McCormack TA, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, Plamondon L, Stein L, Dick LR Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin β-lactone. Biochemistry. 37:1998;7792-7800.
21. Shimbara N, Ogawa K, Hidaka Y, Nakajima H, Yamasaki N, Niwa SI, Tanahashi N, Tanaka K Contribution of proline residue for efficient production of MHC class I ligands by proteasomes. J Biol Chem. 273:1998;23062-23071.
22. Shimbara N, Nakajima H, Tanahashi N, Ogawa K, Niwa S-I, Uenaka A, Nakayama E, Tanaka K Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region. Genes Cells. 2:1997;785-800.
23. Bogyo M, Shin S, McMaster JS, Ploegh H Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem Biol. 5:1998;307-320. Here, inhibitors based on tri- and tetra-peptidic vinyl sulfones were tested for binding to the β-type subunits of the proteasome. Interestingly, the P4 position was more important for defining specific binding than P1-P3. This specificity for residues distal to the cleavage site indicates distinct substrate-binding by the catalytic β-type subunits, which differ in the immunoproteasome. Subunit-specific inhibitors will be useful tools to study the role of individual subunits in antigen processing.
24. Realini C, Dubiel W, Pratt G, Ferrell K, Rechsteiner M Molecular cloning and expression of a gamma-interferon-inducible activator of the multicatalytic protease. J Biol Chem. 269:1994;20727-20732.
25. Tanahashi N, Yokoto KY, Ahn JY, Chung CH, Fujiwara T, Takahashi E, DeMartino GN, Slaughter CA, Toyonaga T, Yamamura K Molecular properties of the proteasome activator PA28 family proteins and γ-interferon regulation. Genes Cells. 2:1997;195-211.
26. Paesen GC, Nuttall PA A tick homolog of the human Ki nuclear autoantigen. Biochim Biophys Acta. 1309:1996;9-13.
27. Kandil E, Kohda K, Ishibashi T, Tanaka K, Kasahara M PA28 subunits of the mouse proteasome: primary structures and chromosomal localization of the genes. Immunogenetics. 46:1997;337-344.
28. Ahn K, Erlander M, Leturcq D, Peterson PA, Früh K, Yang Y In vivo characterization of the proteasome regulator PA28. J Biol Chem. 271:1996;18237-18242.
29. Song X, Mott JD, von Kampen J, Pramanik B, Tanaka K, Slaughter CA, DeMartino GN A model for the quaternary structure of the proteasome activator PA28. J Biol Chem. 271:1996;26410-26417.
30. Johnston SC, Whitby FG, Realini C, Rechsteiner M, Hill CP The proteasome 11S regulator subunit REGα (PA28α) is a heptamer. Protein Sci. 6:1997;2469-2473.
31. Knowlton JR, Johnston SC, Whitby FG, Realini C, Zhang Z, Rechsteiner M, Hill C Structure of the proteasome activator REGα (PA28α). Nature. 390:1997;639-643. This demonstrates the crystal structure of PA28α; the paper shows that PA28α is a heptameric ring with a central cavity. A model of how PA28 associates with the proteasome is presented which can be used to further characterize the interaction between PA28 and the 20S proteasome.
32. •] revealed that mutations which cause a defect in heteromer assembly mapped to the central portion of the regulator whereas mutations affecting binding to and/or activation of the proteasome localize to the bottom part of the PA28 structure. PA28 subunits which bind, but do not activate, the proteasome could serve as dominant-negative mutants useful for studying the role of PA28 in antigen presentation in vivo.
33. Kuehn L, Dahlmann B Reconstitution of proteasome activator PA28 from isolated subunits: optimal activity is associated with an α,β-heteromultimer. FEBS Lett. 394:1996;183-186.
34. Realini C, Jensen CC, Zhang Z-g, Johnston SC, Knowlton JR, Hill C, Rechsteiner M Characterization of recombinant REGα, REGβ, and REGγ proteasome activators. J Biol Chem. 272:1997;25483-25492.
35. Song X, Von Kampen J, Slaughter CA, Demartino GN Relative functions of the α and β subunits of the proteasome activator, PA28. J Biol Chem. 272:1997;27994-28000.
36. Wilk S, Chen W-E Synthetic peptide-based activators of the proteasome. Mol Biol Rep. 24:1997;119-124.
37. Dick TP, Ruppert T, Groettrup M, Kloetzel PM, Kuehn L, Koszinowski UH, Stevanovic S, Schild H, Rammensee HG Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell. 86:1996;253-262.
38. ••].
39. Hendil KB, Khan S, Tanaka K Simultaneous binding of PA28 and PA700 activators to 20S proteasomes. Biochem J. 332:1998;749-754. This study shows that complexes consisting of 20S proteasomes together with PA28 and the ATPase complex co-immunoprecipitate. Thus it seems likely that ubiquitinated protein degradation, which requires the ATPase complex, can be modulated by PA28.
40. Groettrup M, Soza A, Eggers M, Kuehn L, Dick TP, Schild H, Rammensee HG, Koszinowski UH, Kloetzel PM A role for the proteasome regulator PA28α in antigen presentation. Nature. 381:1996;166-168.
41. ••], it is suggested here that precursor peptides are degraded in a two-step process to generate MHC-binding peptides. Endoproteolytic cleavage of the carboxy-terminal ends of peptides can be inhibited by lactacystin and thus involves the proteasome. By contrast, the amino-terminal end is generated via trimming by aminopeptidases, in particular leucine aminopeptidase. Since leucine aminopeptidase is upregulated by IFN-γ [42], this enzyme might be generally involved in antigen processing.
42. Harris CA, Hunte B, Krauss MR, Taylor A, Epstein LB Induction of leucine aminopeptidase by interferon-γ. Identification by protein microsequencing after purification by preparative two-dimensional gel electrophoresis. J Biol Chem. 267:1992;6865-6869.
43. Anton LC, Snyder HL, Bennink JR, Vinitsky A, Orlowski M, Porgador A, Yewdell JW Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. J Immunol. 160:1998;4859-4868.
44. Vinitsky A, Anton LC, Snyder HL, Orlowski M, Bennink JR, Yewdell JW The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing? J Immunol. 159:1997;554-564.
45. Lopez D, Del Val M Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation. J Immunol. 159:1997;5769-5772.
46. Yellen-Shaw A, Wherry EJ, Dubois GC, Eisenlohr LC Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full length protein. J Immunol. 158:1997;3227-3234.
47. Luckey CJ, King GM, Marto JA, Venketeswaran S, Maier BF, Crotzer VL, Colella TA, Shabanowitz J, Hunt DF, Engelhard VH Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J Immunol. 161:1998;112-121.
48. Schmidtke G, Eggers M, Ruppert T, Groettrup M, Koszinowski UH, Kloetzel P-M Inactivation of a defined active site in the mouse 20S proteasome complex enhances major histocompatibility complex class I antigen presentation of a murine cytomegalovirus protein. J Exp Med. 187:1998;1641-1646. This study shows that an overexpressed, mutated, inactive LMP2 subunit incorporated into the proteasomal complex results in reduced overall peptide production. Surprisingly, however, LMP2 inactivation increased the production of a particular epitope. Targeted mutation of proteasome subunits could facilitate the understanding of the functional consequences of IFN-γ-induced structural changes.
49. Benham AM, Gromme M, Neefjes J Allelic differences in the relationship between proteasome activity and MHC class I peptide loading. J Immunol. 161:1998;83-89.
50. Fenteany G, Schreiber SL Lactacystin, proteasome function and cell fate. J Biol Chem. 273:1998;8545-8548.
51. Glas R, Bogyo M, McMaster JS, Gaczynska M, Ploegh HL A proteolytic system that compensates for loss of proteasome function. Nature. 392:1998;618-622. This study shows that EL-4 cells developed resistance to inactivation of the proteasome that is caused by irreversible inhibitors. As a compensatory mechanism, a high-molecular-weight protease seems to be upregulated which might be similar to the one described in [52]. Since this protease seems to be able to provide all proteasomal functions, including peptide production for antigen presentation by MHC class I, it might also normally contribute to antigen processing.
52. Osmulski PA, Gaczynska M A new large proteolytic complex distinct from the proteasome is present in the cytosol of fission yeast. Curr Biol. 8:1998;1023-1026.